Tumor-bearing mice were treated with PBS, PD-L1 antibody, PD-L1/VISTA bispecific antibody control, PD-L1 FolTAC, or PD-L1/VISTA FolTAC-dual v1.0. This evidence concerns the gene CD274 and neoplasm.